D-1460-2016 Class II Terminated
FDA drug recall D-1460-2016 was initiated by Zydus Pharmaceuticals USA Inc on Jul 19, 2016 and is designated Class II. Reason for recall: Failed Dissolution Specifications: out of specification dissolution results in retained samples The recall status is terminated (terminated Sep 21, 2020). Affected quantity: 223,776 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 24, 2016
- Initiation Date
- Jul 19, 2016
- Termination Date
- Sep 21, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 223,776 bottles
Product description
Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottles (NDC 68382-036-16), and c) 1000-count bottles, (NDC 68382-036-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.
Reason for recall
Failed Dissolution Specifications: out of specification dissolution results in retained samples
Distribution pattern
Nationwide
Code information
Lot #: a) MR10518, Exp. 9/2017; MR11051, MR11052, MR11053, MR11054, Exp. 10/2017; MR11403, Exp. 11/2017. Lot #: b) MR10197, MR10195, Exp. 09/2017; MR11482, Exp.10/2017; MR11479, MR11480, MR11481, MR11483, MR11665 Exp. 11/2017. Lot #: c) MR10404, MR10406, MR10521, Exp. 09/2017; MR10744, MR11055, MR11228, MR11287, MR11285, MR11288, MR11289, MR11286, Exp.10/2017; MR11567, Exp.11/2017.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1460-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026